Raymond James Trust’s Amsurg Corp AMSG Stock Holding History

Raymond James Trust’s Portfolio AMSG Stock Details AMSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,148	Closed	-$547K	–	740
2016 Q3	$547K	Buy	8,148 +3,106	+62%	+$217K	0.05%	315
2016 Q2	$391K	Buy	5,042 +223	+5%	+$17.2K	0.03%	387
2016 Q1	$359K	Buy	4,819 +540	+13%	+$38K	0.03%	410
2015 Q4	$325K	Buy	4,279 +947	+28%	+$75K	0.03%	428
2015 Q3	$259K	Sell	3,332 -284	-8%	-$21.9K	0.03%	465
2015 Q2	$252K	Sell	3,616 -48	-1%	-$3.21K	0.03%	503
2015 Q1	$225K	Buy	+3,664	New	+$211K	0.02%	545

Other funds holding AMSG

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Raymond James Trust's AMSG Position: Q4 2016 in Review

Raymond James Trust sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 8,148 shares — an estimated $547K sold.

Raymond James Trust first reported a position in AMSG in Q1 2015 and held it in 7 quarters. The position peaked at $547K in Q3 2016. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

Raymond James Trust reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
Raymond James Trust sold 8,148 Amsurg Corp shares in Q4 2016, an estimated $547K.
Raymond James Trust first reported a position in Amsurg Corp in Q1 2015 and held it in 7 quarters.
Raymond James Trust's Amsurg Corp position peaked at $547K in Q3 2016.
7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on Raymond James Trust's 13F filing for Q4 2016, filed 19 Jan 2017.